KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to $243.7 million.

  • Ionis Pharmaceuticals' Prepaid Assets rose 3233.0% to $243.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $243.7 million, marking a year-over-year increase of 3233.0%. This contributed to the annual value of $217.9 million for FY2024, which is 608.52% up from last year.
  • According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Prepaid Assets is $243.7 million, which was up 3233.0% from $226.1 million recorded in Q2 2025.
  • Ionis Pharmaceuticals' Prepaid Assets' 5-year high stood at $243.7 million during Q3 2025, with a 5-year trough of $123.8 million in Q1 2021.
  • Over the past 5 years, Ionis Pharmaceuticals' median Prepaid Assets value was $174.1 million (recorded in 2024), while the average stood at $175.1 million.
  • In the last 5 years, Ionis Pharmaceuticals' Prepaid Assets crashed by 680.97% in 2021 and then surged by 3233.0% in 2025.
  • Quarter analysis of 5 years shows Ionis Pharmaceuticals' Prepaid Assets stood at $143.4 million in 2021, then grew by 17.35% to $168.3 million in 2022, then grew by 22.1% to $205.4 million in 2023, then rose by 6.09% to $217.9 million in 2024, then rose by 11.84% to $243.7 million in 2025.
  • Its last three reported values are $243.7 million in Q3 2025, $226.1 million for Q2 2025, and $222.6 million during Q1 2025.